Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT B-lymphocyte antigen CD19 binding agent PubMed

Cross References

Resources Reference
ChEMBL CHEMBL2109308